Literature DB >> 28965825

The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D.

Lucy Liu1, Kevin R MacKenzie2, Nagireddy Putluri3, Mirjana Maletić-Savatić4, Hugo J Bellen5.   

Abstract

Elevated reactive oxygen species (ROS) induce the formation of lipids in neurons that are transferred to glia, where they form lipid droplets (LDs). We show that glial and neuronal monocarboxylate transporters (MCTs), fatty acid transport proteins (FATPs), and apolipoproteins are critical for glial LD formation. MCTs enable glia to secrete and neurons to absorb lactate, which is converted to pyruvate and acetyl-CoA in neurons. Lactate metabolites provide a substrate for synthesis of fatty acids, which are processed and transferred to glia by FATP and apolipoproteins. In the presence of high ROS, inhibiting lactate transfer or lowering FATP or apolipoprotein levels decreases glial LD accumulation in flies and in primary mouse glial-neuronal cultures. We show that human APOE can substitute for a fly glial apolipoprotein and that APOE4, an Alzheimer's disease susceptibility allele, is impaired in lipid transport and promotes neurodegeneration, providing insights into disease mechanisms.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOE2; APOE3; APOE4; ARSAL; Aats-met; Alzheimer’s disease; CMT2A; Drosophila melanogaster; Leigh syndrome; MARS2; Marf; Mitofusin; Mus musculus; NDUFAF6; astrocytes; reactive oxygen species; sicily

Mesh:

Substances:

Year:  2017        PMID: 28965825      PMCID: PMC5677551          DOI: 10.1016/j.cmet.2017.08.024

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  112 in total

1.  Identification of X-linked genes required for migration and programmed cell death of Drosophila melanogaster germ cells.

Authors:  Clark R Coffman; Rachel C Strohm; Fredrick D Oakley; Yukiko Yamada; Danielle Przychodzin; Robert E Boswell
Journal:  Genetics       Date:  2002-09       Impact factor: 4.562

2.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity.

Authors:  Laura L Listenberger; Xianlin Han; Sarah E Lewis; Sylvaine Cases; Robert V Farese; Daniel S Ory; Jean E Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 3.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

Authors:  David A Elliott; Cyndi Shannon Weickert; Brett Garner
Journal:  Clin Lipidol       Date:  2010-08-01

Review 5.  Fatty acid transport proteins, implications in physiology and disease.

Authors:  Melissa Kazantzis; Andreas Stahl
Journal:  Biochim Biophys Acta       Date:  2011-09-25

6.  Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis.

Authors:  Joanne R Doherty; Chunying Yang; Kristen E N Scott; Michael D Cameron; Mohammad Fallahi; Weimin Li; Mark A Hall; Antonio L Amelio; Jitendra K Mishra; Fangzheng Li; Mariola Tortosa; Heide Marika Genau; Robert J Rounbehler; Yunqi Lu; Chi V Dang; K Ganesh Kumar; Andrew A Butler; Thomas D Bannister; Andrea T Hooper; Keziban Unsal-Kacmaz; William R Roush; John L Cleveland
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

7.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization.

Authors:  L Pellerin; P J Magistretti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

8.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

9.  An enhanced monomeric blue fluorescent protein with the high chemical stability of the chromophore.

Authors:  Oksana M Subach; Paula J Cranfill; Michael W Davidson; Vladislav V Verkhusha
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

10.  The FATP1-DGAT2 complex facilitates lipid droplet expansion at the ER-lipid droplet interface.

Authors:  Ningyi Xu; Shaobing O Zhang; Ronald A Cole; Sean A McKinney; Fengli Guo; Joel T Haas; Sudheer Bobba; Robert V Farese; Ho Yi Mak
Journal:  J Cell Biol       Date:  2012-08-27       Impact factor: 10.539

View more
  126 in total

1.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

2.  Human VPS13A is associated with multiple organelles and influences mitochondrial morphology and lipid droplet motility.

Authors:  Wondwossen M Yeshaw; Marianne van der Zwaag; Francesco Pinto; Liza L Lahaye; Anita Ie Faber; Rubén Gómez-Sánchez; Amalia M Dolga; Conor Poland; Anthony P Monaco; Sven Cd van IJzendoorn; Nicola A Grzeschik; Antonio Velayos-Baeza; Ody Cm Sibon
Journal:  Elife       Date:  2019-02-11       Impact factor: 8.140

3.  Axonal Ensheathment in the Nervous System of Lamprey: Implications for the Evolution of Myelinating Glia.

Authors:  Marie-Theres Weil; Saskia Heibeck; Mareike Töpperwien; Susanne Tom Dieck; Torben Ruhwedel; Tim Salditt; María C Rodicio; Jennifer R Morgan; Klaus-Armin Nave; Wiebke Möbius; Hauke B Werner
Journal:  J Neurosci       Date:  2018-06-25       Impact factor: 6.167

Review 4.  Insulin resistance and impaired lipid metabolism as a potential link between diabetes and Alzheimer's disease.

Authors:  Joshua A Kulas; Thaddeus K Weigel; Heather A Ferris
Journal:  Drug Dev Res       Date:  2020-02-05       Impact factor: 4.360

5.  Loss- or Gain-of-Function Mutations in ACOX1 Cause Axonal Loss via Different Mechanisms.

Authors:  Hyung-Lok Chung; Michael F Wangler; Paul C Marcogliese; Juyeon Jo; Thomas A Ravenscroft; Zhongyuan Zuo; Lita Duraine; Sina Sadeghzadeh; David Li-Kroeger; Robert E Schmidt; Alan Pestronk; Jill A Rosenfeld; Lindsay Burrage; Mitchell J Herndon; Shan Chen; Amelle Shillington; Marissa Vawter-Lee; Robert Hopkin; Jackeline Rodriguez-Smith; Michael Henrickson; Brendan Lee; Ann B Moser; Richard O Jones; Paul Watkins; Taekyeong Yoo; Soe Mar; Murim Choi; Robert C Bucelli; Shinya Yamamoto; Hyun Kyoung Lee; Carlos E Prada; Jong-Hee Chae; Tiphanie P Vogel; Hugo J Bellen
Journal:  Neuron       Date:  2020-03-12       Impact factor: 17.173

Review 6.  Lactate in the brain: from metabolic end-product to signalling molecule.

Authors:  Pierre J Magistretti; Igor Allaman
Journal:  Nat Rev Neurosci       Date:  2018-03-08       Impact factor: 34.870

7.  Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis.

Authors:  Patrycja Puchalska; Shannon E Martin; Xiaojing Huang; Justin E Lengfeld; Bence Daniel; Mark J Graham; Xianlin Han; Laszlo Nagy; Gary J Patti; Peter A Crawford
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

8.  Glial Metabolic Rewiring Promotes Axon Regeneration and Functional Recovery in the Central Nervous System.

Authors:  Feng Li; Armin Sami; Harun N Noristani; Kieran Slattery; Jingyun Qiu; Thomas Groves; Shuo Wang; Kelly Veerasammy; Yuki X Chen; Jorge Morales; Paula Haynes; Amita Sehgal; Ye He; Shuxin Li; Yuanquan Song
Journal:  Cell Metab       Date:  2020-09-16       Impact factor: 27.287

Review 9.  Using Drosophila to drive the diagnosis and understand the mechanisms of rare human diseases.

Authors:  Nichole Link; Hugo J Bellen
Journal:  Development       Date:  2020-09-28       Impact factor: 6.868

Review 10.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.